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Background: Caligid copepods, also called sea lice, are fish ectoparasites, some species of which cause significant
problems in the mariculture of salmon, where the annual cost of infection is in excess of €300 million globally. At
present, caligid control on farms is mainly achieved using medicinal treatments. However, the continued use of a
restricted number of medicine actives potentially favours the development of drug resistance. Here, we report
transcriptional changes in a laboratory strain of the caligid Lepeophtheirus salmonis (Krøyer, 1837) that is moderately
(~7-fold) resistant to the avermectin compound emamectin benzoate (EMB), a component of the anti-salmon louse
agent SLICE® (Merck Animal Health).
Results: Suppression subtractive hybridisation (SSH) was used to enrich transcripts differentially expressed between
EMB-resistant (PT) and drug-susceptible (S) laboratory strains of L. salmonis. SSH libraries were subjected to 454
sequencing. Further L. salmonis transcript sequences were available as expressed sequence tags (EST) from
GenBank. Contiguous sequences were generated from both SSH and EST sequences and annotated. Transcriptional
responses in PT and S salmon lice were investigated using custom 15 K oligonucleotide microarrays designed using
the above sequence resources. In the absence of EMB exposure, 359 targets differed in transcript abundance
between the two strains, these genes being enriched for functions such as calcium ion binding, chitin metabolism
and muscle structure. γ-aminobutyric acid (GABA)-gated chloride channel (GABA-Cl) and neuronal acetylcholine
receptor (nAChR) subunits showed significantly lower transcript levels in PT lice compared to S lice. Using RT-qPCR,
the decrease in mRNA levels was estimated at ~1.4-fold for GABA-Cl and ~2.8-fold for nAChR. Salmon lice from the
PT strain showed few transcriptional responses following acute exposure (1 or 3 h) to 200 μg L-1 of EMB, a drug
concentration tolerated by PT lice, but toxic for S lice.
Conclusions: Avermectins are believed to exert their toxicity to invertebrates through interaction with glutamate-
gated and GABA-gated chloride channels. Further potential drug targets include other Cys-loop ion channels such
as nAChR. The present study demonstrates decreased transcript abundances of GABA-Cl and nAChR subunits in
EMB-resistant salmon lice, suggesting their involvement in avermectin toxicity in caligids.
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Figure 1 Susceptibility of salmon louse laboratory strains to
emamectin benzoate (EMB). Toxicity responses of adult male
salmon lice (Lepeophtheirus salmonis) laboratory strains S and PT in
24 hours immotility bioassays. Symbols represent the immotility
response observed in one of duplicate beakers of ten individuals
included for each combination of strain and treatment. Dose–response
relationships (solid lines) were established using probit analysis, and
yielded EC50 values of 73.9 μg L-1 (95% confidence intervals:
58.9 - 92.0 μg L-1) for the S strain and 642.3 μg L-1 (642.3 - 957.4 μg L-1)
for the PT strain.
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The development of synthetic insecticides and parasiti-
cides has revolutionised the control of arthropod pests
and parasites of agricultural, medical and veterinary
importance. However, the overuse of chemical control
agents tends to promote the development of heritable
insecticide or drug resistance [1], with life-cycle traits of
targeted organisms often favouring the ability to adapt
genetically, such as high reproductive potential and short
generation span. Drug resistance can follow from pre-
existing mutations in resistance genes, termed resistance
alleles, which under normal conditions are rare and have
a negative or neutral effect on fitness but which, under
conditions of exposure to control agents, afford fitness
benefits and can become enriched in the target species’
gene pool given persisting selection pressure from the
control agent [2]. By the time resistance becomes appar-
ent as treatment failure, resistance alleles have usually
already reached high frequencies in the gene pool [2].
Caligid copepods, also called sea lice, are common ecto-
parasites of marine fish [3]. One species, the salmon louse
(Lepeophtheirus salmonis (Krøyer, 1837)), has emerged as
a serious problem in mariculture of Atlantic salmon
(Salmo salar Linnaeus, 1758) in the Northern hemisphere.
The annual cost of sea louse infection to the global salmon
farming industry has been estimated at €300 million, with
the majority of this accounted for through expenses ac-
crued from treatments with veterinary medicines [4]. Only
a limited range of anti-sea louse drugs are available and
licensed for the treatment of fish, and the continued use
of a relatively small number of compounds creates a situ-
ation potentially favouring the development of drug resist-
ance [5]. In the salmon louse, losses of efficacy have been
reported for a number of control agents including organo-
phosphates [6], pyrethroids [7], hydrogen peroxide [8] and
avermectins (AVMs) [9,10].
The commonly used anti-sea louse treatment SLICE®
(Merck Animal Health) contains the avermectin com-
pound emamectin benzoate (EMB) (Stone et al., 1999).
SLICE® is administered orally and a one-week treatment
provides prolonged protection against all host-attached life
stages of sea lice [11]. Avermectins are also used against
external and internal parasites of humans and livestock,
including parasitic nematodes causing the human diseases
onchocerciasis (River blindness) and lymphatic filariasis,
as well as gastrointestinal parasites of sheep, cows and
horses [12]. The selective toxicity of avermectins against
ecdysozoan invertebrates is believed to be based on the
binding and blockage of glutamate-gated (GluCl) and
γ-aminobutyric acid (GABA)-gated (GABA-Cl) chloride
channels in the invertebrate nervous system [13]. Several
molecular mechanisms have been suggested as contribut-
ing factors to the resistance of parasitic nematodes to
the AVM compound ivermectin (IVM) [14]. Functionalstudies revealed that resistant nematodes can have single
amino acid mutations in subunits of GluCl and GABA-Cl
that decrease the channels’ sensitivities to the drug [15,16].
Furthermore, resistant nematodes may show increased
expression of ABC (ATP-binding cassette) transporters, a
group of membrane proteins with members capable of
mediating the cellular efflux of drugs [17,18]. Finally, aver-
mectin resistance in insects has been connected to alter-
ations in drug metabolism [19].
Previous studies on potential molecular mechanisms
of EMB resistance in salmon lice have used the candi-
date gene approach, i.e. the study of genes that have pre-
viously been linked to drug resistance in other
organisms. In particular, such studies have investigated
salmon louse ABC transporters [9,20] and GABA-Cl and
GluCl subunits [21]. However, potential outcomes
resulting from such candidate approaches are limited by
the current knowledge of the biological process being
studied. To avoid this limitation, a transcriptomic
approach was followed in the present study, in which
microarray analysis was used to compare mRNA re-
sponses between drug susceptible and moderately
(~7-fold) EMB resistant laboratory strains of salmon lice.
Results
Experimental design
Two laboratory-maintained strains of salmon lice were
used in the present study. Strain S is susceptible to all
currently licensed anti-sea louse treatments including
EMB, while strain PT is moderately resistant to EMB
(Figure 1) [9]. Adult male salmon lice were used for the
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vide a more steady physiological state than adult
females, which undergo considerable morphological
change following fertilisation and which are subject to
repeated cycles of egg production. Salmon lice were
collected from host fish anaesthetised in 100 mg L-1
2-phenoxyethanol and were then allowed to recover in
aerated seawater for 2 hours before use.
In experiment 1, RNA expression profiles were
analysed in lice sampled directly after recovery in order
to reveal differences in constitutive gene expression
between strains. Experiment 2 investigated the effects of
short-term (1 to 3 hours) exposure to 200 μg L-1
of EMB, compared to seawater and carrier controls
(Figure 2). This concentration of EMB resulted in >95%
immotility of S lice after 24 hours, but had no observ-
able effects on PT lice (Figure 1). We hypothesised that,
should the tolerances of PT lice to EMB require tran-
scriptional regulation, this should become apparent in
transcriptomic profiles during the early stages (1 and
3 hours) of exposure. In addition to being investigated
for effects of EMB, the data from experiment 2 were also
analysed with respect to differences in constitutive tran-
script expression between strains. For this purpose, data
for the one and three hour sea water controls from
experiment 2 were pooled for each strain in order to ob-
tain the same level of replication as used in experimentn = 3
Seawater 1 h
Seawater 3 h
PEG3001 h
PEG3003 h
EMB 1 h
EMB 3 h
Strain S
(Susceptible)
Experiment 2
Strain S
(Susceptible)
Experiment 1
untreated
n = 6
Figure 2 Design of microarray experiments. Microarray analysis was use
resistant (PT) salmon louse strains. In experiment 1, adult male salmon lice
In experiment 2, salmon lice were removed from hosts and then subjected
3 hours before sampling. Control treatments included exposures to seawat
solubilise EMB. The number of pools of four salmon lice sampled for each1 (n = 6 biological replicates, i.e. pools of four L.
salmonis). Control data from experiment 2 were pooled
between 1 and 3 hour time points as we had previously
observed that exposure of salmon lice to seawater for up to
12 hours after collection from the host has no effect on re-
sponses to EMB in water-borne bioassays (data not shown).
Custom microarray design
For transcriptomic analyses, custom Agilent 15 K feature
60mer oligonucleotide microarrays were designed using
sequences derived from salmon louse suppression
subtractive hybridisation (SSH) libraries created in the
present study together with expressed sequence tags
(EST) publicly available in GenBank. Although the
microarrays differed in a minor way between experi-
ments 1 and 2 due to continuous elaboration/modifica-
tion, the features included on the microarrays employed
largely overlap (Table 1). To obtain a pool of salmon
louse cDNA sequences enriched for transcripts differen-
tially expressed between the EMB-resistant (PT) and
drug-susceptible (S) salmon louse strains, two SSH librar-
ies were constructed, corresponding to subtractions
between strains in both directions. A pool of both libraries
was subjected to Roche 454 sequencing, producing a total
of 94,834 reads (N50 value of 289 nucleotides). The
assembly of contiguous sequences (contigs) from sequence
reads provided 1,916 annotated (BLASTx e-value <10-4)Seawater 1 h
Seawater 3 h
PEG3001 h
PEG3003 h
EMB 1 h
EMB 3 h
Strain PT
(Resistant)
Strain PT
(Resistant)
untreated
n = 6
n = 3
d to measure transcriptomic profiles in drug-susceptible (S) or EMB
were collected for RNA extraction directly after removal from host fish.
to exposure of seawater containing 200 μg L-1 of EMB for 1 or
er, or seawater containing the solvent PEG300, which was used to
combination of treatment and strain is given as n.
Table 1 Composition of features on custom L. salmonis
oligo microarrays
Probe type Experiment 1
(AMADID # 039612)
Experiment 2
(AMADID # 033382)
Annotated 13, 542 10,056
Unannotated 1,566* 5,052*
Control probes 100 100
Agilent controls 536 536
Total 15744 15744
* Oligo probes were designed to both the forward and reverse complement
sequence for all targets that were not suitably annotated but included on the
custom microarrays.
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analysis of the annotated sequences revealed a large repre-
sentation (53%) of genes involved in metabolism (data not
shown). In addition, 129,225 L. salmonis ESTs (> 100 bp)
were obtained from GenBank and assembled into contigs,
providing a further 10,056 annotated (BLASTx e-value
<10-4) and 2,526 un-annotated target sequences for the
design of oligo probes to be used in the microarray designs
(Table 1).
Analysis of strain differences in constitutive gene expression
To determine constitutive differences in gene expression
between the PT and S strains, mRNA expression profiles
were analysed in adult male salmon lice sampled in
February 2012 (experiment 1) and May 2011 (seawater
controls of experiment 2). When data from each experi-
ment were analysed including only features present on
both microarrays, similar numbers of features were
found to be differentially expressed between strains in
experiment 1 and experiment 2 (1,113 and 1,280 features
respectively; Figure 3). Comparison of these two feature
lists revealed that only 359 features were reported as
being significantly differentially expressed between
strains in both experiments. Of these, 294 (82%) showed
the same direction of strain differences in the two exper-
iments (Figure 3) and represented 226 genes of which
57% were annotated. These 226 genes were arranged by
significance of the expression differences determined in
experiment 1.
Genes that were represented in the top 100 most sig-
nificantly differentially expressed transcripts are detailed
in Table 2, which includes a substantial number of cyto-
skeleton proteins (26%) and proteases (12%). Enrichment
analysis of the 294 features resulting from comparison of
expression between strains was performed with respect
to the gene ontology (GO) annotation representation on
the microarray. Nine GO attributes were found to be
significantly over-represented (Additional file 1), with
calcium ion binding, structural constituent of muscle
and actin binding being shown to be the most signifi-
cantly over-represented GO terms.To confirm findings from microarray analyses, tran-
script abundance was analysed for a sub-set of signifi-
cantly differentially expressed genes using RT-qPCR.
Genes were selected on the basis of potential signifi-
cance as pharmacological targets of EMB (GABA-Cl
subunit alpha and neuronal acetylcholine receptor sub-
unit α3), or detoxification mechanisms (cytochrome
P450 isoforms, carboxylesterase). Maltase-glucoamylase
was further included because of its high level of differen-
tial expression (105-fold) between salmon louse strains.
RT-qPCR analysis found that transcripts of nAChR α-3
were ~3.1-fold and ~2.6-fold less abundant in the PT
than the S strain in experiments 1 and 2 respectively,
which confirmed trends observed in the microarray ana-
lyses (Table 3). Similarly, RT-qPCR demonstrated that
PT lice showed significantly lower levels of GABA-Cl
α-subunit mRNA expression compared to the S strain
(1.4-fold and 1.6-fold in experiments 1 and 2, respect-
ively; Table 3), although differences were marginal.
Isoforms of cytochrome P450 and carboxylesterase, i.e.
enzymes potentially involved in detoxification, were
found to show higher mRNA expression levels in the PT
compared to the S strain in experiment 1, but not
experiment 2. Transcript levels of maltase-glucoamylase
were much lower in PT than S lice in experiment 1,
whereas in experiment 2 the mRNA expression was
moderately increased in PT compared to S lice (Table 3).
Effects of short-term exposure to EMB on transcript
profiles in salmon lice
Three-way ANOVA of the microarray expression data
from experiment 2 showed that a large proportion (55%)
of the total number of features that passed quality filter-
ing (n = 10,804) was affected by the factor strain. In con-
trast, the factor treatment had a comparatively small
influence on gene expression (Table 4). To confirm these
microarray results, transcript abundances were deter-
mined by RT-qPCR for six selected genes. Genes were
selected so as to include a number of qualitatively differ-
ent expression profiles, detectable fold-changes and
selected candidate genes (GABA-α and AChR-α3
subunits) (Figure 4). A high degree of correlation was
observed between expression values measured by both
methods (Pearson correlation coefficients (r) of 0.71 to
0.99; p <0.0001).
To further investigate the effects of EMB exposure, a
list of those features that were significantly affected by
EMB treatment or for which significant interactions be-
tween treatment and other factors were observed (treat-
ment × strain; treatment × time; treatment × strain ×
time) was compiled. This list comprised a total of 2,020
features, of which at least 35% were involved in metabol-
ism (KEGG functional classification, data not shown).
Transcript abundance profiles for the 2,020 features
Experiment 1
921359754
Experiment 2
Experiment 1
Expression 
change (PT/S)
Experiment 2
Expression 
change (PT/S)
Number of 
features
Number of 
genes
Down Down 235 (66%) 180
Up Up 59 (16%) 46
Down Up 40 (11%) 37
Up Down 25 (7%) 21
Total 359 284
226*
Figure 3 Comparison of microarray features differentially expressed across salmon louse strains between experiments. Genes
differentially expressed between two salmon lice strains differing in EMB susceptibility (S, PT) were determined by microarray analysis in two
independent experiments. Features that showed differential expression between strains (fold change ≥ 1.3, p < 0.05) were derived for both
experiments. The Venn diagram only includes features studied in both experiments. *A total of 226 genes showed comparable differential
expression between salmon louse strains in two independent microarray experiments and were therefore selected for further analysis of
biological function.
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BioLayout Express3D application [22]. This resulted in
the resolution of 59 clusters with a minimum cluster size
of four features. The two main clusters 1 and 2
contained 418 and 62 features, respectively, that showed
fold changes > 1.3 across all conditions (Figure 5A &
B). Within the two clusters, expression profiles were
characterised by pronounced responses in S lice follow-
ing 1 h of EMB exposure (down-regulation in cluster 1,
up-regulation in cluster 2), and a full or partial return to
basal expression levels after 3 h of EMB exposure. More-
over, for genes in both clusters, few if any responses to
EMB exposure were observed in the PT strain.
The most significantly differentially regulated genes
from cluster 1, and the responses to EMB exposure in
both salmon louse strains are summarised in Additional
file 2. An analogous selection of genes from cluster 2 is
provided in Additional file 3. Genes in cluster one in-
clude the GABA-Cl and nAChR α-3 subunits which are
potential targets for EMB, with nAChR α-3 also having
been identified as constitutively differentially expressedbetween salmon louse strains. Genes in cluster two in-
cluded a glutathione-S-transferase isoform and a nAChR
α-3 precursor. Enrichment analysis of the features in
cluster one is detailed in Additional file 4, showing sig-
nificant over representation of twelve and under repre-
sentation of four GO attributes. Chitin binding, calcium
ion binding and hydrolase activity were the most signifi-
cantly over-represented attributes and nucleic acid bind-
ing was identified as the most significant under
represented attribute.
Discussion
Using transcriptional profiling in comparative studies of a
drug-susceptible and an EMB-resistant salmon louse
strain, this study demonstrated the reduced constitutive
mRNA expression of subunits of certain ligand-gated ion
channels (LGIC) in the EMB resistant strain, namely a
GABA-gated chloride channel subunit (GABA-Cl, ~1.4-
fold decreased) and a neuronal acetylcholine receptor
subunit (nAChR α-3; ~2.8-fold decreased). The toxicity of
EMB and other AVMs against ecdysozoan invertebrates is
Table 2 Genes showing differential expression between salmon louse strains differing in EMB susceptibility
Accession no. Annotation Experiment 1 Experiment 2
Fold change (PT/S) p-value Fold change (PT/S) p-value
Ligand gated ion channel (<1%)
ADD24187.1 Neuronal acetylcholine receptor subunit alpha-3 −3.21 7.59E-05 −2.52 4.29E-03
Metabolism of xenobiotics (<1%)
ACO15001.1 Cytochrome P450 3A24 −1.48 1.95E-03 −1.31 4.13E-02
Regulation of synapse development (<1%)
ADD24462.1 Cerebellin-3 −1.86 3.60E-04 −4.91 3.53E-06
Eye lens proteins (<1%)
ADD38111.1 Beta-crystallin A1 2.33 6.79E-05 1.37 1.35E-02
Transporters (2%)
NP_001116712.1 Solute carrier family 8 (sodium/calcium exchanger) −2.10 3.63E-04 −4.38 1.74E-05
EFX88361.1 Alpha subunit of Na+/K+ ATPase −1.67 2.21E-04 −2.08 5.34E-05
ACO12613.1 Excitatory amino acid transporter 3 −1.42 1.10E-04 −1.34 4.96E-02
Cytoskeleton proteins (26%)
ADD38332.1 Troponin I −1.77 4.85E-05 −2.61 1.17E-06
XP_001950563.1 Muscle LIM protein −1.67 1.57E-04 −2.30 1.32E-06
AAA17371.1 Fast myosin heavy chain −2.11 1.73E-03 −6.23 1.68E-06
ACO13186.1 Myosin light chain alkali −2.65 1.69E-05 −3.38 8.46E-06
ACO12924.1 Myosin light chain alkali −2.06 1.16E-05 −3.69 9.66E-06
ABU41018.1 Collagen alpha-1 chain −1.38 1.51E-03 −6.85 2.61E-05
EFV61840.1 Smoothelin −1.43 4.03E-04 −1.85 6.25E-05
ACO12887.1 Troponin T −1.73 1.04E-03 −2.93 8.12E-05
ADV40202.1 Troponin 1 −1.94 1.87E-03 −2.93 3.23E-04
AAW22542.1 Myosin light chain −1.76 1.00E-03 −2.23 3.73E-04
ACO10528.1 Troponin C, isoform 1 −1.91 1.69E-03 −2.22 5.12E-04
ACO12630.1 Troponin C, isoform 1 −1.61 3.01E-05 −1.51 5.92E-04
ACO12421.1 Tropomodulin −1.51 1.17E-04 −2.37 1.01E-03
ACO12794.1 Troponin C, isoform 1 −2.07 6.14E-05 −1.60 2.85E-03
ACO14751.1 Troponin C, isoform 1 −2.12 4.94E-05 −1.56 4.18E-03
ACO11818.1 Torso-like protein precursor −1.83 5.11E-05 −1.82 9.67E-03
ACO11077.1 Troponin C, isoform 1 −1.92 6.27E-05 −1.48 1.56E-02
Regulation of actin cytoskeleton (<1%)
XP_002407362.1 Paxillin −2.79 8.32E-07 −1.48 2.28E-03
Calcium transport (<1%)
NP_001032719.1 Sarco/endoplasmic reticulum calcium transporting ATPase −2.15 8.58E-07 −2.46 2.15E-04
Calcium binding (1%)
XP_002734090.1 Calmodulin-like −1.60 6.41E-05 −2.46 3.25E-04
ACO11757.1 Sarcoplasmic calcium-binding protein, beta chain −3.18 2.05E-06 −3.58 1.28E-03
Cuticle proteins (4%)
ADD24515.1 Cuticle protein 6 −2.29 1.79E-03 −12.28 4.75E-04
ABU41025.1 Cuticle protein −2.57 2.78E-04 −12.91 1.88E-03
ACO14885.1 Cuticle protein CP14.6 precursor −1.77 7.50E-04 −3.40 4.67E-03
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Table 2 Genes showing differential expression between salmon louse strains differing in EMB susceptibility (Continued)
Proteolysis (12%)
ADD38666.1 Matrix metalloproteinase-9 −2.29 1.07E-05 −7.35 1.84E-06
ADD38283.1 Kunitz/BPTI-like toxin −2.45 5.43E-06 −1.79 2.50E-04
ABU41053.1 Metalloproteinase −5.61 7.00E-06 −4.38 3.99E-04
BAG74353.1 Metalloproteinase 14.83 8.20E-05 18.61 4.64E-04
ACO11096.1 Serine carboxypeptidase CPVL precursor 1.58 2.44E-04 1.36 1.21E-02
ABU41117.1 Metalloproteinase −2.72 6.62E-05 −1.41 1.82E-02
AAS91793.1 Intestinal trypsin 2 precursor 7.73 1.90E-06 1.82 2.52E-02
AAS91795.1 Intestinal trypsin 4 precursor 1.48 6.69E-04 1.42 2.79E-02
Annotated genes (57%) were sorted by the significance of differential expression between strains in experiment 1 and arranged by biological function. Features
with identical annotation were removed prior to categorising biological function. Also indicated is the percentage representation for each functional category in
the total number of annotated genes (129 genes).
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another class of LGICs, the glutamate-gated chloride
channels (GluCl) [23-25] although GABA-Cls are also be-
lieved to be pharmacological targets of AVMs [26]. While
nAChRs are traditionally not considered to be implicated
in the toxic action of AVMs in ecdysozoans, they can be
allosterically modulated by IVM [27]. This study’s finding
that mRNA levels of GABA-Cl and nAChR subunits are
decreased in EMB-resistant salmon lice suggests that these
LGICs may represent potentially additional target sites for
AVMs in sea lice. When transcriptomic profiles of EMB-
resistant and -susceptible laboratory salmon louse strains
were investigated in response to short term (1–3 h) aque-
ous EMB exposure, a number of transcriptional responses
to the treatment were observed in the drug-susceptible S
lice, but few responses were found in the EMB-resistant
PT strain. While we cannot exclude the possibility that
EMB exposure might provoke more pronounced
transcriptomic responses in PT lice at later time points,
differential toxicity of EMB between the louse strains isTable 3 Gene expression measured by RT-qPCR in salmon lice
Accession no. Annotation Experiment 1
Microarray RT-qPCR
p-value Fold
change
(PT/S)
p-value Fold
chan
(PT/S
ADD24187.1 Neuronal acetylcholine
receptor subunit α3
7.59E-05 −3.21 0.000 −3.0
EFN73916.1 GABA receptor subunit
alpha
NS −1.19 0.015 −1.3
XP_003494528.1 Cytochrome p450 18a1 3.42E-08 3.34 0.000 3.14
AAS13464.1 Cytochrome p450 15a1 8.93E-04 2.14 0.000 1.82
NP_001136104.1 Carboxylesterase 1.13E-04 1.38 0.041 1.21
XP_797271.2 Maltase-glucoamylase 9.12E-05 −104.50 0.000 −194.
Abbreviations: NS Not significantly different (p<0.05), N/A Not applicable.
For selected genes, mRNA expression was measured in salmon lice from two strain
compared to findings obtained in microarray analyses. Significance (p < 0.05) asses
analysis. Fold changes ≥ 1.3 are underlined.apparent as early as 5 hours post-exposure (data not
shown). This suggests that the mechanism of resistance,
whether constitutive, responsive or a combination of both,
must have occurred before this time point. The present
study only considered levels of mRNA. Molecular mecha-
nisms underlying differential susceptibilities between the
studied strains could also include post-transcriptional
regulatory mechanisms, such as mRNA processing and
degradation, translation and protein degradation [28],
however, these lay outside the scope of the present study.
AVMs are used against parasitic and pest species of
ecdysozoan invertebrates including nematodes, insects
and mites, and more recently against crustaceans. While
the molecular target sites of AVMs in crustaceans are
unknown, GluCls are generally considered to be the
main pharmacological targets of IVMs in nematodes and
insects [29,30]. The GluCls form an invertebrate-specific
subgroup of the large ‘Cys-loop’ subfamily of LGIC.
‘Cys-loop’ LGICs have a pentameric structure, and are
composed of either the same type of subunits or two tofrom two strains differing in EMB susceptibility
Experiment 2
Pearson
correlation
Microarray RT-qPCR Pearson
correlation
ge
)
r p-value p-value Fold
change
(PT/S)
p-value Fold
change
(PT/S)
r p-value
8 0.93 <0.0001 4.29E-03 −2.52 0.009 −2.64 0.89 0.0001
5 N/A N/A 2.05E-04 −1.75 0.005 −1.56 0.89 0.0001
0.95 <0.0001 N/A NS 1.00 N/A N/A
0.95 <0.0001 N/A NS 1.09 N/A N/A
0.65 0.02 NS 1.12 NS 1.12 N/A N/A
85 0.99 <0.0001 7.10E-03 1.72 0.017 2.00
s differing in EMB susceptibility (see Figure 1 for information on strains), results
sed by t-test (Welch) for microarray analysis and one-way ANOVA for RT-qPCR
Table 4 Number of differentially expressed features
identified in microarray analysis of samples from
experiment 2
Experimental factor Number of features
Strain 5940 (55%)
Treatment 369 (3%)
Time 968 (9%)
Strain x Treatment 406 (4%)
Strain x Time 950 (9%)
Time x Treatment 1309 (12%)
Strain x Treatment x Time 1701 (16%)
Significance (p-value < 0.05) assessed by three-way ANOVA. Also indicated is
the percentage of the total number of features (10, 804) used in the analysis.
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of GluCl as the main target of AVMs, IVM-resistant
strains of invertebrates can show mutations changing
the expression levels or the peptide sequence of channel
subunits [23,24]. A GluClα subunit has been cloned in
L. salmonis [21] and while GluClα was represented
amongst the microarray targets used for this study, no
difference in mRNA expression was observed between
salmon lice of the two studied strains, or amongst those
subjected to control and sublethal EMB treatments (data
not shown).
Apart from GluCl, further LGICs are known to inter-
act with AVMs. For instance, IVM modulates the activity
of nematode GABA-Cl [26], and can exert directly acti-
vating or potentiating effects on vertebrate glycine-gated
chloride channels [31]. Moreover, AVMs can modulate
the activity of cation-LGICs such as the α-7 nAChR [27]
and the ATP-gated P2X4 receptors [32]. A number of
observations involving drug-resistant insects and nema-
todes support the hypothesis that LGICs other than
GluCl constitute further toxicologically relevant targets
of AVMs in invertebrates. Cyclodiene-resistant fruit flies
having a single amino acid mutation in a GABA-Cl
showed a moderate degree of cross-resistance to IVM
[24]. A null mutation in a histamine-gated chloride
channel also conferred moderate IVM resistance in
Drosophila melanogaster Meigen, 1830 [33], and a novel
dopamine-gated ion channel (HcGGR3) was significantly
down-regulated in an AVM-selected strain of the nema-
tode Haemonchus contortus (Rudolphi, 1803) [34]. The
observation in this study that EMB-resistant salmon lice
show decreased mRNA levels of nAChR and GABA-Cl is
consistent with findings in the literature cited above, and
suggests a role for nAChR and GABA-Cl as additional
pharmacological targets of EMB in salmon lice. It is
worth noting in this context that observed changes in
nAChR expression could also relate to previous exposure
of PT lice to compounds interfering with cholinergicneurotransmission such as the organophosphate (OP)
anti-sea louse drug azamethiphos [35]. However, decreases
in nAChR expression are not among typical molecular re-
sponses associated with OP resistance in insects [1,36].
While decreased expression of nAChR has been observed
in nematodes resistant to imidazothiazoles and other drugs
that directly target nAChR channels [14], these are classes
of compound that have not been used against sea lice.
Apart from modifications of the molecular targets,
biocide resistance in pests and parasites can result from
increased elimination of the chemical as a result of
up-regulation of biotransformation enzymes and/or drug
transporters. The superfamily of cytochrome P450s
(CYPs) contains heme-thiolate proteins that function as
monooxygenases, many of which are involved in drug
metabolism [37,38]. CYPs play important roles as chem-
ical resistance genes in insects [1,39], but their roles in
the biochemical defence against toxicants in crustaceans
are less well understood. The microarrays used in the
present study included probes representing a number of
target sequences that are annotated as CYPs (experiment
1: 18 probes; experiment 2: 14 probes). These partial
L. salmonis CYP sequences could not be unequivocally
attributed to specific CYP families, as this would require
establishing the overall degree of amino acid similarity
to CYP family members [40]. However, based on
BLASTx annotation (e-values of ≤ 10-7), most of these
sequences could be provisionally allocated to CYP clans,
which are higher-order groupings that combine phylo-
genetically related CYP families [40] (Clan 2: 6
sequences; clan 3: 5 sequences; mitochondrial clan: 3
sequences). Two targets showing similarity to CYP15A1
and CYP18A1 (both clan 2) differed in mRNA expres-
sion in L. salmonis from experiment 1, but not experi-
ment 2. Moreover, compared to the EMB susceptible
strain a target showing similarity to CYP3A24 (clan 3)
had lower expression levels in the EMB resistant strain,
with a moderate (1.48-fold) difference in transcript
abundance found between the strains. In insects,
CYP15A1 is involved in juvenile hormone synthesis [41],
whereas CYP18A1 functions to inactivate ecdysteroids
[42]. Crustaceans possess homologues to both these clan 2
CYPs [43], but little is known of their function. In the
green shore crab (Carcinus maenas) expression levels of
two CYPs from clan 2 were affected by both the moulting
cycle and previous exposure to xenobiotics [44]. The
differences in CYP mRNA levels found in this study were
relatively small and/or variable between experiments and
therefore do not provide clear evidence for an involvement
of CYPs in the differential EMB susceptibility found in the
salmon louse strains that were studied.
Carboxylesterases are another class of enzymes that
can confer insecticide resistance [1]. In this study, the
expression of one carboxylesterase was moderately
Strain S Strain PT
Figure 4 Gene expression responses at early time points of exposure to EMB. Shown are the relative expression ratios (RER) measured by
microarray and RT-qPCR analysis of S and PT salmon louse strains after 1 and 3 hours exposure to 200 μg L-1 EMB, seawater (SW), or the solvent
PEG300 (SOL) . Data are Log2 RER ± SE (n = 3).
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Figure 5 Relative expression profiles for the features in network clusters one (A) and two (B). A total of 418 (cluster 1) and 62 (Cluster 2)
features (fold change ≥ 1.3 in S strain) were clustered using network analysis. The similarity of expression profiles were measured using the
Pearson correlation coefficient and clustered using the Markov clustering algorithm (MCL).
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but no significant differences in expression were ob-
served between strains in experiment 2. Accordingly, the
data provides no evidence for a role of carboxylesterase
in EMB resistance of salmon lice.
ABC (ATP-binding cassette) proteins are a family of
membrane-bound transporters mediating the transport
of a diverse array of substrates across biological mem-
branes [45]. Certain ABC proteins are drug efflux trans-
porters located in the cell membrane, and have roles in
the biochemical defence against toxicants [46]. The ABCtransporter P-glycoprotein transports IVM [47] and has
relevance as a biochemical factor limiting the drug’s
toxicity in mice and nematodes [18,48]. It has been
suggested that P-glycoprotein could be implicated in the
resistance of pests and parasites to AVMs [49-51], and a
salmon louse homologue of P-glycoprotein called SL-
PGY1 has been cloned [9]. In the present study, mRNA
expression of SL-PGY1 was unaffected by EMB treat-
ment and did not differ between S and PT strains (data
not shown), confirming similar data previously reported
for these strains [9].
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tween louse strains in the absence of drug exposure, the
present study also addresses transcriptomic responses of
both louse strains to short-term exposures (1 to 3 hours)
to 200 μg L-1 of EMB. The selected EMB concentration
is not toxic to the resistant salmon louse strain, but in
the drug-susceptible strain it results in close to 100%
immotility after 24 hours exposure. After 1 to 3 hours of
exposure, few transcriptomic responses were observed in
the resistant strain, and therefore these data do not
provide evidence for the presence of specific resistance
mechanisms requiring transcriptional regulation. In the
drug-susceptible strain, a complex array of transcriptional
responses to EMB was observed. This finding was
expected, as this level of EMB exposure was known to
result in significant toxic responses after 24 hours. Early
transcriptional responses are therefore likely to comprise
both adaptive and general stress responses, as well as tran-
scriptional changes reflecting the toxic action of the drug.
Conclusions
The transcriptional profiling of a drug susceptible and
an EMB resistant laboratory strain of salmon lice re-
vealed reduced mRNA expression of a number of LGIC
subunits in the EMB resistant lice. GluCl, considered to
be the major target site of AVM drugs in invertebrates,
displayed similar mRNA expression levels in EMB-
resistant and reference strains. In contrast, subunits of
GABA-Cl and nAChR showed decreased mRNA abun-
dances in the EMB resistant compared to the reference
strain. While GABA-Cl is considered a secondary target
of AVMs in invertebrates, nAChR is not traditionally
considered a target site for AVMs, even though it has
been shown to interact with AVMs in vertebrates. It is
possible that nAChR and GABA-Cl represent additional
EMB target sites in salmon lice, and that the down-
regulation of these channel subunits in this EMB-
resistant strain could be related to the resistance pheno-
type. In the present study no changes were seen in the
expression levels of biotransformation enzymes and drug
transporters, both of which classes have been suggested
to contribute to AVM resistance in other species. Fur-
ther studies are needed to investigate potential relation-
ships between the transcriptional changes observed and
the susceptibility phenotype.
Methods
Salmon louse strains
Two laboratory-maintained salmon louse (L. salmonis)
strains differing in susceptibility to EMB [9], were used
in this study. The susceptible strain S was established
in 2003 using salmon lice from a Scottish farm site
where no chemical control agents other than hydrogen
peroxide had been used. The moderately EMB-resistantsalmon louse strain PT was established in December
2008 using salmon lice from another Scottish production
site with reports of variable EMB treatment efficacies.
The strains have since been cultured under identical la-
boratory conditions, as described in detail elsewhere [9].
In brief, salmon lice were maintained on Atlantic salmon
(S. salar) with an initial weight of 500–1000 g in circu-
lar tanks supplied with fresh seawater at ambient
temperature, using a photoperiod corresponding to nat-
ural day length. To propagate salmon louse cultures, egg
strings were allowed to hatch and develop to copepodids,
which were used to inoculate a tank containing fresh host
fish. Prior to the collection of salmon lice from hosts, fish
were anaesthetised with 100 mg L-1 2-phenoxyethanol. In-
fection rates were maintained at levels that were unlikely
to compromise fish welfare. All laboratory infections were
carried out under UK Home Office licence and appropri-
ate veterinary supervision.
Salmon louse exposure experiments
Adult male salmon lice were collected from anaes-
thetised host fish as described above and allowed to re-
cover for 2 hours in aerated filtered seawater at ambient
sea temperature. To analyse transcript expression in
salmon louse strains S and PT in the absence of drug
exposure (microarray experiment 1), adult males were
collected and preserved in an RNA stabilisation solution
(4.54 M ammonium sulphate, 25 mM trisodium citrate,
20 mM EDTA, pH 5.4) prior to storage at −70°C. For
both strains six pooled samples comprising four individ-
uals each were taken. The effects of acute seawater-
borne exposure to EMB on transcript expression were
investigated in microarray experiment 2. In order to
establish the EMB concentration for this experiment,
24 hour bioassays [52] were carried out on salmon louse
strains S and PT. EMB (technical grade, a gift from
Merck Animal Health) was solubilised in seawater with
PEG300 (final concentration 0.01% (v/v)). EMB concen-
trations used in bioassays were 32.5, 75, 150, 300 and
600 μg L-1 with S lice, and 200, 400, 800, 1,600 and
3,200 μg L-1 with PT lice. Duplicate glass dishes
containing 10 salmon lice and 200 mL of exposure solu-
tion were used per EMB concentration, control (sea-
water) or solvent control (seawater with 0.01% (v/v)
PEG300). At the end of 24 hours of exposure, salmon lice
were recorded as normally motile or immotile upon
visual examination and stimulation with a fine brush. To
generate samples for microarray experiment 2, salmon
lice of either strain were subjected to short term (1 and
3 hour) exposures to 200 μg L-1 EMB, a concentration
that would result in >95% immotility in S lice after
24 hours but have no effects in PT lice. In addition, the
experiment comprised seawater and solvent (0.01% (v/v)
PEG300) controls. For each combination of strain,
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consisting of four salmon lice each were collected for
later RNA extraction as above. None of the treatments
had effects on louse motility. At the end of the experi-
ment (3 hours), water samples were taken and sent to a
commercial laboratory (Eclipse Scientific, Chatteris, UK)
for EMB residue analysis (liquid chromatography with
detection by MSMS). The measured EMB concentration
in the nominal 200 μg L-1 EMB treatment was 99.5 ±
5.2 μg L-1 EMB. This depletion of solubilised active
ingredient may be attributed to EMB adsorption to the
glass containers used for exposure assays [53].
RNA extraction and purification
In microarray and RT-qPCR experiments, samples were
pools of four adult male salmon lice. Frozen samples
were ground in liquid nitrogen using a pestle and mor-
tar, and total RNA was immediately extracted from
the homogenised sample using TRI Reagent® (Sigma-
Aldrich, UK), following the manufacturer’s protocol.
After phase separation, RNA was precipitated from the
aqueous phase by addition of 0.25 volumes isopropanol
and 0.25 volumes of a high salt buffer (0.8 M trisodium
citrate; 1.2 M sodium chloride), as recommended for
samples with high polysaccharide content [54]. The total
RNA was resuspended in nuclease-free water and fur-
ther purified using RNeasy columns (Qiagen, UK). For
the construction of subtracted cDNA libraries, total
RNA from 60 untreated adult males from either strain
(S or PT) were pooled and subjected to poly (A)+ RNA
isolation using the Poly (A) Purist™ kit (Ambion®, UK).
UV spectroscopy (NanoDrop ND-1000, Thermo Scien-
tific, USA) was used to confirm purity of the RNA sam-
ples and establish concentrations, whereas RNA
integrity was assessed by agarose gel electrophoresis and
ethidium bromide staining.
Subtracted cDNA library construction and sequencing
Suppression subtractive hybridisation (SSH) was used to
prepare cDNA libraries enriched in transcripts differen-
tially expressed between strains S and PT using com-
mercial methods (PCR-Select™, Clontech, Takara Bio
Inc., USA) . Subtractions were performed in both direc-
tions, i.e. using cDNA derived from each strain (S or
PT) either as the tester or the driver. A pool of cDNA
from each subtraction, containing an equal amount of
both subtracted cDNA libraries, was used for generating
a 454 sequencing library using the GS FLX Titanium
Rapid Library Preparation kit (Roche Applied Science,
UK), following manufacturer’s instructions. Adaptive
Focus Acoustics™ (AFA™) using the S220 High Perform-
ance Ultrasonicator (Covaris® Inc., KBiosciences, UK)
was employed to randomly shear the cDNA, blunt ends
were repaired and MID adapters ligated to the DNAfragments prior to sequencing using the Genome
Sequencer™ (GS) Titanium FLX instrument (Roche Ap-
plied Science, UK) (EBI Sequence Read Archive (SRA)
study ERP002190). GS FLX Titanium library preparation
and sequencing was performed by The GenePool Gen-
omics Facility (University of Edinburgh, UK). Sequence
reads were assembled using the GS De Novo
Assembler (Newbler) v2.5.3 software (Roche Applied
Science, UK) using default parameters after trimming of
MID adapter and primer sequences.
Sequence assembly from existing L. salmonis EST
resource
A total of 129,225 sequences (> 100 bp) were downloaded
during December 2010 for L. salmonis from the GenBank
EST database (as described by Yasuike et al.) [55], and
assembled into contigs using default assembly settings of
The Gene Indices Clustering Tools (TGICL), obtained
from the Computational Biology and Functional Genom-
ics Laboratory (The Gene Index Project, USA). Prior to
sequence assembly, vector sequences were removed using
SeqMan II 6.1 (DNAStar Inc., USA).
Salmon louse microarray design
The assembled contig sequences were annotated using
BLASTx (Basic Local Alignment Search Tool) searches
against the non-redundant proteins (nr), UniprotKB/
Swiss-Prot (Swissprot) and Reference Proteins (Refseq_
Proteins) GenBank databases at the National Centre for
Biotechnology Information (NCBI), with an annotation
hit having an expectation value (e-value) of <1 × 10-4
being considered significant. All sequences were fur-
ther annotated with GO identifiers using Blast2Go soft-
ware for Windows® using Java Webstart (Centro de
Investigación Príncipe Felipe, Spain). Oligonucleotide
probes (60mers) were designed to target contig se-
quences using the eArray Gene Expression (GE) probe
design tool (Agilent Technologies, UK), employing the
base composition and best probe methodologies, and
designed in sense orientation with 3’ bias. For each se-
quence without a significant BLASTx based annotation
two probes were selected; designed to both forward and
reverse complement sequences. Standard expression
microarrays were designed using the eArray custom
microarray design wizard (Agilent Technologies, UK) for
an 8 × 15 K design format. Each microarray comprised
15,744 features including 536 obligatory controls
(Table 1). An initial design was used for experiment 1
interrogations (Agilent AMADID No 039612; EBI
ArrayExpress design A-MEXP-2285). This design incor-
porated probes designed to target 2,699 sequences that
were identified when sequencing the subtracted cDNA
libraries enriched for transcripts differentially expressed
between the EMB-resistant (PT) and drug susceptible
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each of the SSH targets. Experiment 2 employed a
modified design (Agilent AMADID No 033382; EBI
ArrayExpress design AMEXP-2284). The array designs
shared 10,251 identical features.
Microarray analyses
Labelling protocols are described in detail elsewhere [56].
Briefly, for each test sample 250 ng total RNA was used as
template for the amplification of antisense RNA with the
incorporation of the modified nucleotide 5-(3-aminoallyl)-
UTP (aaUTP) into the amplified RNA (aRNA) during the
in vitro transcription step (TargetAmp™ Aminoallyl-aRNA
Amplification Kit 101; Epicentre®, Cambio Ltd. UK). A
common reference pool was created through pooling
equal amounts of all aRNA test samples to be used in the
experiment. The individual test samples were labelled with
cyanine 3 (Cy3) and the common reference pool labelled
with Cy5 mono-reactive dye (GE Healthcare, UK) in dye
coupling reactions. Unincorporated dye was removed by
column purification (Illustra Autoseq™ G-50 spin columns;
GE healthcare, UK), and then dye incorporation was
assessed by spectrophotometry (NanoDrop ND-1000,
Thermo Scientific, USA) and fluorescent gel electrophor-
esis. Three hundred nanograms of each Cy3-labelled test
sample was competitively hybridised with 300 ng Cy5-
labelled common reference pool on a 15 K feature custom
microarray, following the manufacturer’s instructions
(Agilent Technologies, UK). The hybridisation reactions
were incubated at 65°C with 10 rpm rotation for 17 hours
in an Agilent rotary hybridisation oven and then washed
with Gene Expression Wash Buffers 1 and 2, with a final
wash using Stabilisation and Drying solution, again follow-
ing the manufacturer’s instructions (Agilent Technologies,
UK). The hybridised microarrays were scanned using an
Axon Genepix 4200A scanner with Genepix Pro 6.1 image
acquisition software (Molecular Devices, UK) using 40%
laser power, 5 μm pixel size resolution and auto photo-
multiplier tube (auto-PMT) function with 0.05 saturation
tolerances. The raw microarray images were processed
using Agilent Feature Extraction (FE) software version
9.5.3.1 that performed feature grid alignment, extraction
and quantification. The fluorescence intensity results files
from the FE software were imported into the GeneSpring
GX version 12 software (Agilent Technologies, UK) for
differential gene expression analysis. Data were normalised
using Lowess normalisation of log2-expression ratios
without baseline transformation. Features showing low
quality according to Agilent quality control metrics were
discarded to provide a final feature set for analysis. Details
of microarray experiments 1 and 2 have been submitted to
ArrayExpress and assigned accession numbers E-MTAB
-1484 (Experiment 1) and E-MTAB-1478 (Experiment 2).
The recording of the microarray experimental metadatacomplies with Minimum Information About a Microarray
Experiment (MIAME) guidelines.
RT-qPCR
To validate gene expression results from microarray
experiments, the abundance of selected differentially
expressed transcripts was determined by reverse transcrip-
tion quantitative PCR (RT-qPCR). Per experiment, three
targets that showed stable expression levels in microarray
hybridisations were selected as reference genes. (Experi-
ment 1: 60S ribosomal protein S20, 40S ribosomal protein
L44 and RMD-5 homolog; experiment 2: Hypoxanthine-
guanine phosphoribosyltransferase (HGPRT), RMD-5
homolog and Elongation factor 1α). For each target
sequence, primers were designed with a melting tempe-
rature (Tm) of ~60°C using Primer 3 software (Additional
file 5). Aliquots (1 μg) of total RNA samples previously
used in microarray analyses were reverse transcribed
(Superscript III, Invitrogen, UK) using random hexamers
and anchored oligo-dT in a 3:1 molar ratio. No-template
controls and controls omitting RT enzyme were included
on each assay plate to detect potential DNA contamin-
ation. A cDNA pool containing equal amounts of all sam-
ples was made and included on each assay plate, serving
as a calibration sample (20-fold dilution) and for deriv-
ation of a standard curve from serial dilutions. RT-qPCR
reactions were performed in duplicate in a total volume of
20 μL containing 5 μL sample cDNA (20-fold dilution),
0.3 μM of each primer and 10 μL Absolute SYBR Green I
mix (ThermoFisher Scientific, UK), using the Mastercycler
ep realplex2 (Eppendorf, UK) with the following amplifica-
tion conditions: 95°C for 15 minutes, followed by 40 cycles
of 94°C for 30 seconds, 15 seconds at the specific primer
pair annealing temperature (Ta; Additional file 5) and 72°C
for 30 seconds. After amplification a melt curve from 55°C
to 95°C at 0.5°C increments for 15 seconds each was
performed to ensure that a single product was amplified
in each reaction. Threshold cycles were analysed using the
PCR cycler software. Standard curves were derived from
plots of the threshold cycle against the logarithm of the
relative concentration of cDNA pool. Primer efficiency (E)
was derived from linear fits to the standard curve
according to the equation E = 10(−1/slope). The BestKeeper
tool [57] was employed to analyse expression stability of
three reference genes and determine a robust BestKeeper
expression index as a geometric mean for the three refer-
ence genes, which was in turn used to establish relative
gene expression ratios using the ΔΔCt method using the
Relative Expression Software Tool (REST) Multiple Con-
dition Solver (MCS) [58].
Statistical analysis
Microarray gene expression data were analysed using
GeneSpring GX version 12 (Agilent Technologies). The
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periments 1 and 2 used Student’s t-test adapted for sam-
ples with unequal variance (Welch) using a fold change
threshold of 1.3. The analysis of differential gene expres-
sion induced in microarray experiment 2 employed two-
way ANOVA to compare exposure of both salmon louse
strains at two time points against control conditions.
Multiple testing corrections were not applied to any stat-
istical analysis of this gene expression study as this can
often be over-conservative when studying potentially
subtle gene expression responses to stimuli [56,59]. This
decision is supported by confirmation of differential
expression by RT-qPCR in the current study. Network
analysis of microarray experiment 2 expression data was
performed using the BioLayout Express3D application
[22]. A network graph was constructed using the Pear-
son correlation coefficient (threshold of 0.94) to deter-
mine similarities between expression profiles, which
were then arranged into groups of features with similar
profiles using the Markov clustering algorithm (MCL)
with the default inflation setting (2.2) for optimal clus-
tering. Gene enrichment analysis was performed on lists
of features chosen based on differential gene expression
patterns using default settings of the FuncAssociate 2.0
web application [60]. Gene enrichment was calculated
according to the significance (p< 0.05) of the association
between the list of features and the GO attributes repre-
sented on the microarray. Relative expression ratios
from RT-qPCR experiments were tested for normality
and equal variance and log transformed to allow as-
sumptions to be satisfied before being subjected to one
way ANOVA using Minitab 16.1 software (Minitab Inc.,
UK). The significance level was set at p<0.05 in all tests.
Additional files
Additional file 1: Enrichment of GO classes in the list of features
showing differential expression between salmon louse strains.
Additional file 2: Genes identified from the features grouped in
network cluster 1. Changes in expression of genes in cluster 1 (Figure 5)
observed following exposure of two salmon louse strains to EMB, expressed
relative to gene expression in the matching solvent (SOL) control. Annotated
genes (35%) are arranged by category of biological function. Features with
identical annotation were removed prior to categorising biological function.
Fold changes in expression ≥ 1.3 are underlined.
Additional file 3: Genes identified from the features grouped in
network cluster 2. Changes in expression of genes in cluster 2 (Figure 5)
observed following exposure of two salmon louse strains to EMB,
expressed relative to gene expression in the matching solvent (SOL)
control. For further details, please see legend of additional file 2.
Additional file 4: Enrichment of GO classes among features of
network cluster 1.
Additional file 5: Primers used for RT-qPCR analysis of relative gene
expression between salmon louse strains (experiments 1 and 2).
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